{"organizations": [], "uuid": "5b927303c8e3240130d80208112f44aa2a1d9042", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-abeona-therapeutics-appoints-carst/brief-abeona-therapeutics-appoints-carsten-thiel-as-chief-executive-officer-idUSASC09UFX", "country": "US", "domain_rank": 408, "title": "BRIEF-Abeona Therapeutics Appoints Carsten Thiel As Chief Executive Officer", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-02T15:17:00.000+03:00", "replies_count": 0, "uuid": "5b927303c8e3240130d80208112f44aa2a1d9042"}, "author": "", "url": "https://www.reuters.com/article/brief-abeona-therapeutics-appoints-carst/brief-abeona-therapeutics-appoints-carsten-thiel-as-chief-executive-officer-idUSASC09UFX", "ord_in_thread": 0, "title": "BRIEF-Abeona Therapeutics Appoints Carsten Thiel As Chief Executive Officer", "locations": [], "entities": {"persons": [{"name": "carsten thiel", "sentiment": "negative"}, {"name": "timothy j. miller", "sentiment": "none"}], "locations": [], "organizations": [{"name": "brief-abeona therapeutics", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "abeona therapeutics inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 2, 2018 / 12:19 PM / in 5 minutes BRIEF-Abeona Therapeutics Appoints Carsten Thiel As Chief Executive Officer Reuters Staff \nApril 2 (Reuters) - Abeona Therapeutics Inc: \n* APPOINTS CARSTEN THIEL, PH.D., AS CHIEF EXECUTIVE OFFICER \n* TIMOTHY J. MILLER WILL REMAIN PRESIDENT AND ASSUME POSITION OF CHIEF SCIENTIFIC OFFICER Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-02T15:17:00.000+03:00", "crawled": "2018-04-02T15:37:57.003+03:00", "highlightTitle": ""}